Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-22-Speech-1-162"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Information on medicinal products (Community code relating to medicinal products) - Information on medicinal products (Community procedures for the authorisation and supervision of medicinal products) (debate)2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20101122.17.1-162"2
lpv:hasSubsequent	lp_eu:2010-11-22-Speech-1-1632
lpv:speaker	lp:Franz Obermayr2
lpv:spokenAs	substitute; EMPL (2009-07-16--2012-01-18)3 substitute; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2009-09-16--2014-06-30)3 unknown; Freiheitliche Partei Österreichs (2009-07-14--2014-06-30)3 member; Delegation for relations with Iran (2009-09-16--2012-02-12)3 member; REGI (2009-07-16--2012-01-18)3 member; NA (2009-07-14--2014-06-30)3
lpv:translated text	"Madam President, the wellbeing of patients is key here. In order to cover themselves, pharmaceutical companies often include every minor side effect in package leaflets, which, of course, complicates matters greatly. Confused patients tend to change the dose on their own initiative or to discontinue the medication. Moreover, the flood of information via the Internet, some of which is reliable and some not, adds greatly to the confusion and uncertainty. Certified websites are a step in the right direction, but are not yet enough. A further priority is to make the information comprehensible even to those without medical or pharmaceutical qualifications. The package leaflet must be unmistakable and legible. The font size should be increased, particularly for older people. I regret to say that there are third countries that are profiting from the high level of protection in the European pharmaceutical sector. Both original and fake medicines are thus freely available in large quantities in Turkish bazaars. We therefore also need to impose obligations on these third countries in order to put an end to this black market entirely."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph